You are here

Cellectis

AstraZeneca Invests $140M in Cellectis, Secures 44% Stake in CAR-T Specialist

BioSpace

Mon, 05/6/24 - 11:41 am

allogeneic cells

AstraZeneca Drops $245M on Cell and Gene Therapies in Deal with Cellectis

BioSpace

Wed, 11/1/23 - 11:07 am

SITC: Cellectis' off-the-shelf CAR-T for pancreatic cancer and mesothelioma shows activity in mice

Fierce Biotech

Fri, 11/12/21 - 11:41 am

pancreatic cancer

Sanofi, Cellectis team up to pair Lemtrada with allogeneic CAR-Ts; Bristol Myers joins Evotec's drive to advance UK science

Endpoints

Thu, 05/13/21 - 11:59 pm

allogeneic cells

FDA gives Cellectis all clear after patient death halted off-the-shelf CAR-T trial

Endpoints

Wed, 11/18/20 - 11:03 am

clinical trials

Multiple Myeloma

Death in Cellectis off-the-shelf CAR-T trial triggers FDA hold

Fierce Biotech

Tue, 07/7/20 - 10:39 am

Multiple Myeloma

Cellectis boosts its coffers in revised off-the-shelf CAR-T deal with Servier

Endpoints

Wed, 02/19/20 - 09:56 am

Cellectis gene editing patent upheld in Europe

Seeking Alpha

Thu, 11/21/19 - 10:31 am

FDA lifts hold on Cellectis’ CAR-T trial, adds go-slow caveat

Fierce Biotech

Tue, 11/7/17 - 09:38 am

clinical trials

New Guidelines Address CAR-T Immunotherapy Toxicities to Prevent Patient Deaths

Xtalks

Wed, 09/20/17 - 10:41 am

Juno Therapeutics

Patient Death Triggers FDA Hold For Cellectis’s “Off the Shelf” CAR-T

Xconomy

Tue, 09/5/17 - 09:50 am

clinical trials

Medivir out-licenses hep C drug to China’s Ascletis; Cellectis launches pioneering UCART123 US study

Endpoints

Sat, 08/19/17 - 10:29 am

Servier, Pfizer get FDA OK to start US testing of an off-the-shelf CAR-T from Cellectis

Endpoints

Thu, 03/9/17 - 11:34 am

acute lymphocytic leukemia

Pfizer snags U.S. rights to Cellectis' white-hot CAR-T therapy

Fierce Biotech

Fri, 11/20/15 - 11:03 am

immuno-oncology

Cellectis makes history as CAR-T therapy clears terminal leukemia in baby girl

BioPharma Dive

Fri, 11/6/15 - 03:39 pm

Buzz: Cellectis could be in line for a $1.6B Pfizer buyout

Fierce Biotech

Thu, 05/28/15 - 07:20 pm

Cellectis upscales IPO toward $200M as CAR-T fever continues

Fierce Biotech

Wed, 03/25/15 - 09:45 am

Safety concerns cloud early promise of powerful new cancer drugs

Yahoo/Reuters

Mon, 01/26/15 - 08:12 am

Juno Therapeutics

Cellectis Is Late To The CAR-T Cell Race, But Could Finish First

Seeking Alpha

Fri, 01/2/15 - 07:33 pm

Pfizer: Struggling Through A Tough Time

Seeking Alpha

Wed, 07/16/14 - 08:58 am

Pages